Dalmia Bharat Ltd (DALBHARA:IN) PT Raised to INR1,820 at HSBC
- Wall Street ends week positively; S&P 500, Dow hit record highs
- Bitcoin (BTC) Drops 3% as Turkey Bans Cryptocurrency Payments Citing Lack of Regulatory Supervision
- Morgan Stanley (MS) Archegos-Related Loss Appears to be $911M
- Dollar at 4-week low on retreating Treasury yields
- J&J (JNJ) Privately Asked Rival Covid-19 Vaccine Makers to Inspect Clotting Risks, AstraZeneca (AZN) Said Yes but Pfizer (PFE) and Moderna (MRNA) Declined - Report
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
HSBC analyst Vivek Gedda raised the price target on Dalmia Bharat Ltd (DALBHARA:IN) to INR1,820.00 (from INR1,000.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movida Participacoes SA (MOVI3:BZ) PT Lowered to R$20 at Morgan Stanley
- Shinhan Financial Group (055550:KS) (SHG) PT Raised to KRW48,000 at Morgan Stanley
- Hoshizaki Corp. (6465:JP) PT Raised to JPY8,200 at Morgan Stanley
Create E-mail Alert Related CategoriesAnalyst PT Change, Intl Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!